What can be done about Psoriasis?
Unfortunately there is no cure for Psoriasis but there are various treatments available that can help relieve symptoms. Among the most popular treatment methods are: prescription drugs, topical creams, home remedies, and UV phototherapy. Many of the traditional treatments do not deliver dramatic results and involve risky side effects. However, this is all changing with the new XTRAC excimer laser system.
What is XTRAC excimer laser system?
Developed by PhotoMedex, the XTRAC excimer laser is revolutionary treatment method that uses phototherapy to conquer Psoriasis. It works by applying a concentrated light beam that exposes the affected skin to a heavy dosage of monochromatic UVB. This advanced phototherapy treatment provides fast and painless results. Within 6-10 treatments, patients report dramatic improvements with some experiencing complete remission of the disorder after 10-20 treatments. Many of these remissions bring about instant clarity and relief to the skin and can last for over 6 months!
This treatment is FDA approved and has been verified to work in over 45 clinical tests. Aside from delivering amazing results, the XTRAC excimer laser system also includes no harmful side effects.
Why Choose the XTRAC Excimer Laser System?
Psoriasis can be a complicated skin disorder in that no two cases are the same. Depending on the type of Psoriasis and the severity, some treatment methods may work while others may not. As symptoms worsen or cycle, Psoriasis victims may find it irritating to find the perfect treatment that actually works. The downfall with many Psoriasis treatments is that they lack effectiveness and include harmful side effects. This is why the XTRAC treatment is so revolutionary. It is pain free, side-effect free, and it leads to fast relief and in many cases remission. Ask your dermatologist about XTRAC and learn how this new phototherapy is changing the way we look at Psoriasis.
For advertising/promotional opportunities on HealthNewsDigest.com call Mike McCurdy at: 877-634-9180. Email at: [email protected] We have 7,000 journalists as subscribers.